Cargando…
PD-1/PD-L1抑制剂治疗NSCLC脑转移的免疫机制与临床研究进展
Brain metastasis (BM) is a common complication in non-small cell lung cancer (NSCLC), which associates with poor prognosis. Recently, immune checkpoint inhibitors (ICIs) has revolutionized the treatment of tumors. Programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors could produce a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679223/ https://www.ncbi.nlm.nih.gov/pubmed/32773010 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.31 |